CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

autologous umbilical cord blood

Cell therapyexperimental

Cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders such as cancer. — Wikipedia

Clinical trial activity

123 trials · 117 clinical orgs · 0 marketing orgs

Phase 1
50
Phase 2
67
Phase 3
5
Phase 4
0

Earliest trial started Feb 1, 1993 (NCT00212407)

Timeline

1990s

  1. Jan 1, 1993

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 1997

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2002

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Stem CellTissue restoration

    Stem Cell tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • autologous cord blood
  • autologous cord blood cells
  • autologous human cord blood derived stem cells
  • autologous human umbilical cord blood
  • autologous umbilical cord blood
  • autologous umbilical cord blood stem cells
  • ex vivo cd3/cd28 costimulated umbilical cord blood t cells
  • umbilical cord blood

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07201233N/ANov 1, 2025Qilu Pharmaceutical Co., Ltd., Tianjin Medical University
NCT07208344Early Phase 1 (Phase 1)Jul 31, 2025Anhui Medical University
NCT05669079Phase 3Feb 1, 2023Soochow University
NCT04420494N/AApr 20, 2022Chinese Academy of Medical Sciences
NCT05138276Early Phase 1 (Phase 1)Sep 1, 2021Guangdong Women and Children Hospital
NCT04687657Phase 1Jan 1, 2021Jiao Tong University
NCT04243382Phase 2Jan 31, 2020Tel Aviv University
NCT04243408Phase 2Jan 31, 2020Tel Aviv University
NCT04034615Phase 2Oct 20, 2019Maternal and Child Health Hospital of Foshan
NCT04768816Phase 1Jul 1, 2019Guangdong Women and Children Hospital
NCT03779711Phase 2Apr 30, 2019Children's Hospital Los Angeles, Mayo Clinic, University of Colorado, University of Minnesota, University of Oklahoma, University of Pennsylvania
NCT03774537Phase 1/Phase 2 (Phase 2)Mar 1, 2019Chongqing Medical University
NCT03760900Phase 2Mar 1, 2019Guangdong Women and Children Hospital
NCT03855202Phase 1Feb 24, 2019Guangdong Women and Children Hospital
NCT04007224Phase 1Jan 17, 2019Fundatia Bio-Forum, Spitalul Angiomedica
NCT03696745Phase 1Nov 1, 2018Guangdong Women and Children Hospital
NCT03526588Phase 1Aug 1, 2018Texas Medical Center Regenerative Medicine Consortium, University of Texas at Houston
NCT03873506Phase 1Jul 1, 2018Chongqing Medical University
NCT04311476Phase 2Jul 1, 2018Guangdong Women and Children Hospital
NCT03558269Phase 1/Phase 2 (Phase 2)Jun 15, 2018Tel Aviv University
Showing 20 of 123 trials
Page 1 / 7

Organizations

Research & Development (117)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government29241998
University of MinnesotaAcademic/Hospital181741999
Duke UniversityAcademic/Hospital101031998
Guangdong Women and Children HospitalAcademic/Hospital9922017
National Heart, Lung, and Blood Institute (NHLBI)Government9131998
University of Texas at HoustonAcademic/Hospital8432006
University of WashingtonAcademic/Hospital6621998
Case Western Reserve UniversityAcademic/Hospital5531998
State University of New York, BuffaloAcademic/Hospital5511997
Cha Medical UniversityAcademic/Hospital4312010
Cornell UniversityAcademic/Hospital4412006
University of California, San FranciscoAcademic/Hospital4432000
Advent HealthAcademic/Hospital3122011
Cord Blood Registry, Inc.For profit3022011
Tel Aviv UniversityAcademic/Hospital3312018
Baylor UniversityAcademic/Hospital2012011
Blood and Marrow Transplant Clinical Trials NetworkAcademic/Hospital2012006
China Spinal Cord Injury NetworkAcademic/Hospital2122010
Chinese University of Hong KongAcademic/Hospital2022010
Chongqing Medical UniversityAcademic/Hospital2222018
117 organizations
Page 1 / 6